Maria João Carvalho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria João Carvalho has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Anabela Rodrigues
Nephrology Department, Unidade Local de Saúde de Santo António; UMIB - Unidade Multidisciplinar de Investigação Biomédica, ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto; ITR - Laboratory for Integrative and Translational Research in Population Health, UMIB- Unit for Multidisciplinary Research in Biomedicine; Porto, Portugal
6 shared publications - António Cabrita
Centro Hospitalar Universitário do Porto, Portugal
3 shared publications - Joana Tavares
Centro Hospitalar Universitário do Porto, Portugal
3 shared publications - Beatriz Gil Braga
Service de néphrologie, Unidade Local de Saúde de Santo António ; Largo do Professor Abel Salazar, 4050-366, Porto, Portugal
2 shared publications - José Assunção
Nephrology Department, Setubal Hospital Center, Setubal, Portugal
2 shared publications - Olívia Santos
Centro Hospitalar do Porto, Hospital de Santo António, Departamente de Nefrologia, Porto, Portugal
2 shared publications
Latest Publications
- Open Access
- 8 March 2026
- Published by Registre de Dialyse Peritoneale de Langue Francaise (RDPLF) in Bulletin de la Dialyse à Domicile
- Vol. 9 (1) , 1-11
Managing peritoneal dialysis catheter after kidney transplant
Introduction: Peritoneal dialysis is a kidney replacement therapy with outcomes comparable to hemodialysis, although kidney transplantation remains the optimal treatment. The appropriate timing for removing the peritoneal dialysis catheter after transplantation is uncertain, as it may affect patient recovery and graft performance. This study aimed to evaluate infectious complications associated with retained peritoneal dialysis catheters after transplantation and to identify a suitable moment for their removal. Methods: A retrospective review of all patients who underwent kidney transplantation between January 2013 and June 2023 was performed. Descriptive and inferential analyses were used to assess the timing of catheter removal, catheter-related infections, and post-transplant dialysis needs. Continuous variables were analyzed with the Mann-Whitney U test, while nominal variables were evaluated using Chi-square or Fisher’s exact tests. Results: The median time to catheter removal was 4.5 months. Infectious complications occurred in 21 patients, representing 17.2% of the cohort, with exit-site infections being the most frequent event. Donor type and prior infections did not significantly influence infection rates. In living-donor transplantations, only 4.5% of catheters were removed during the transplant surgery. Discussion: These findings support individualized decisions regarding peritoneal dialysis catheter removal, particularly for patients with a low risk of delayed graft function. A risk-based decision algorithm is proposed to assist clinicians. Although current practice aligns with existing guidance, the infectious risks linked to maintaining the catheter suggest that earlier removal should be considered. A tailored approach may improve clinical outcomes and facilitate a safer transition from peritoneal dialysis to kidney transplantation.
- 8 March 2026
- Published by Registre de Dialyse Peritoneale de Langue Francaise (RDPLF) in Bulletin de la Dialyse à Domicile
- Vol. 9 (1) , 1-11
Open AccessManaging peritoneal dialysis catheter after kidney transplant
Introduction: Peritoneal dialysis is a kidney replacement therapy with outcomes comparable to hemodialysis, although kidney transplantation remains the optimal treatment. The appropriate timing for removing the peritoneal dialysis catheter after transplantation is uncertain, as it may affect patient recovery and graft performance. This study aimed to evaluate infectious complications associated with retained peritoneal dialysis catheters after transplantation and to identify a suitable moment for their removal. Methods: A retrospective review of all patients who underwent kidney transplantation between January 2013 and June 2023 was performed. Descriptive and inferential analyses were used to assess the timing of catheter removal, catheter-related infections, and post-transplant dialysis needs. Continuous variables were analyzed with the Mann-Whitney U test, while nominal variables were evaluated using Chi-square or Fisher’s exact tests. Results: The median time to catheter removal was 4.5 months. Infectious complications occurred in 21 patients, representing 17.2% of the cohort, with exit-site infections being the most frequent event. Donor type and prior infections did not significantly influence infection rates. In living-donor transplantations, only 4.5% of catheters were removed during the transplant surgery. Discussion: These findings support individualized decisions regarding peritoneal dialysis catheter removal, particularly for patients with a low risk of delayed graft function. A risk-based decision algorithm is proposed to assist clinicians. Although current practice aligns with existing guidance, the infectious risks linked to maintaining the catheter suggest that earlier removal should be considered. A tailored approach may improve clinical outcomes and facilitate a safer transition from peritoneal dialysis to kidney transplantation.
- Open Access
- 8 September 2024
- Published by Registre de Dialyse Peritoneale de Langue Francaise (RDPLF) in Bulletin de la Dialyse à Domicile
- Vol. 7 (3) , 133-136
A perspective on integrated dialysis access management: in advance of integrated care plan
(To read the full article, in English or French, click on the pdf logo on the right). We would like to draw attention to the critical issue of dialysis access management and vascular access (VA) options in patients transitioning to chronic renal replacement therapy and from peritoneal dialysis (PD) to hemodialysis (HD). We advocate for the establishment of dedicated consultation services for integrated dialysis access management to optimize patient outcomes. We highlight specific cases where a tailored approach to VA selection is essential, emphasizing the importance of risk stratification and timely access preparation. The preferred use of arteriovenous fistula in HD patients and the challenges surrounding its maturation are discussed. We also explore circumstances necessitating urgent versus planned transitions to HD, incorporating considerations for patient-centered care and education. Sonography’s role in managing PD-related infections and the potential benefits of home HD in the transition process are also examined. We suggest the development of scoring systems to predict patient transitions and emphasize the need for an integrated approach to dialysis access management. Overall, we advocate for proactive measures to prevent vascular access failure and ensure a safe and effective transition process for patients with chronic kidney disease.
- 8 September 2024
- Published by Registre de Dialyse Peritoneale de Langue Francaise (RDPLF) in Bulletin de la Dialyse à Domicile
- Vol. 7 (3) , 133-136
Open AccessA perspective on integrated dialysis access management: in advance of integrated care plan
(To read the full article, in English or French, click on the pdf logo on the right). We would like to draw attention to the critical issue of dialysis access management and vascular access (VA) options in patients transitioning to chronic renal replacement therapy and from peritoneal dialysis (PD) to hemodialysis (HD). We advocate for the establishment of dedicated consultation services for integrated dialysis access management to optimize patient outcomes. We highlight specific cases where a tailored approach to VA selection is essential, emphasizing the importance of risk stratification and timely access preparation. The preferred use of arteriovenous fistula in HD patients and the challenges surrounding its maturation are discussed. We also explore circumstances necessitating urgent versus planned transitions to HD, incorporating considerations for patient-centered care and education. Sonography’s role in managing PD-related infections and the potential benefits of home HD in the transition process are also examined. We suggest the development of scoring systems to predict patient transitions and emphasize the need for an integrated approach to dialysis access management. Overall, we advocate for proactive measures to prevent vascular access failure and ensure a safe and effective transition process for patients with chronic kidney disease.
- Open Access
- 14 June 2023
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 38 (Supplement)
#4781 FRAILTY IN PERITONEAL DIALYSIS: PREVALENCE AND PREDICTION FACTORS
Frailty is a clinical syndrome characterized by a state of increased vulnerability and risk of adverse outcomes following a stress, which exerts a heavy economic and social burden. The identification of this syndrome is done throught validated tools. Although frailty is associated with advanced age, certain conditions that produce age-like changes can lead to a state of frailty at younger ages. The presence of multiple comorbidities increases frailty risk. Also, low levels of albumin, even in the normal range, have been related to greater frailty and its levels have been used to assess frailty. Chronic kidney disease is associated with higher prevalence of frailty. However, little has been reported about frailty prevalence in peritoneal dialysis population. Our aim was to access the prevalence of frail and vulnerable PD patients using the Edmonton Frailty Scale (EFS) and to identify prediction factors. In a retrospective cohort study, we assessed frailty in PD patients from 2 center in Portugal by a validated frailty score (Edmonton Frailty Scale-EFS). We also collected information that could contribute to frailty in these patients. Linear and logistic regressions were used to access frailty predictors. Receiver operating characteristics (ROC) curve was used to access accuracy of those predictors. We included 74 PD patients, 51,5% male, mean age 53,9 ± 15,1 years, median body max index 25,2 ± 4,3 Kg/m2. Median CCI was 4 [interquartile range (IQR) of 3]. Fifty-three patients (71,6%) were classified as robust (non-frail), 11 as vulnerable, and 10 as frail (8 mildly and 2 moderate). Patients were divided into two groups: A group included robust (non-frail) patients; B group included vulnerable and frail ones. Age, sex distribution, IMC, diabetes mellitus prevalence, variables related to PD (efficacy, vintage, modality and complications), and levels of hemoglobin, phosphorus, potassium and C-reactive protein were similar between the groups. Non frail patients presented significantly higher albumin levels and lower CCI (p-value < 0,05). A linear regression was performed to ascertain the effects of CCI and albumin: CCI was an independent predictor for frailty/vulnerability, accessed by EFS (for each point in CCI, there was an increase of 0,5 points in EFS). Albumin did not show a significant effect defining frailty in our sample. ROC curve showed a high accuracy for CCI to identify frail/ vulnerable patients (AUC 0,817). In our sample, CCI was an independent factor for frailty/vulnerability classified through EFS. In fact, it had a high accuracy to identify those patients, with a high sensibility. This means that CCI could be used as an acceptable screening test. However, the prevalence of frail/vulnerable patients was low in our sample. A larger one will allow to determine confirm if certain comorbidities, such as diabetes mellitus, or variables related to dialysis technique, are correlated with frailty. Furthermore, a larger sample would be essential to confirm whether albumin is, after all, a good predictor of frailty in the PD population, which was not confirmed in this work.
- 14 June 2023
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 38 (Supplement)
Open Access#4781 FRAILTY IN PERITONEAL DIALYSIS: PREVALENCE AND PREDICTION FACTORS
Frailty is a clinical syndrome characterized by a state of increased vulnerability and risk of adverse outcomes following a stress, which exerts a heavy economic and social burden. The identification of this syndrome is done throught validated tools. Although frailty is associated with advanced age, certain conditions that produce age-like changes can lead to a state of frailty at younger ages. The presence of multiple comorbidities increases frailty risk. Also, low levels of albumin, even in the normal range, have been related to greater frailty and its levels have been used to assess frailty. Chronic kidney disease is associated with higher prevalence of frailty. However, little has been reported about frailty prevalence in peritoneal dialysis population. Our aim was to access the prevalence of frail and vulnerable PD patients using the Edmonton Frailty Scale (EFS) and to identify prediction factors. In a retrospective cohort study, we assessed frailty in PD patients from 2 center in Portugal by a validated frailty score (Edmonton Frailty Scale-EFS). We also collected information that could contribute to frailty in these patients. Linear and logistic regressions were used to access frailty predictors. Receiver operating characteristics (ROC) curve was used to access accuracy of those predictors. We included 74 PD patients, 51,5% male, mean age 53,9 ± 15,1 years, median body max index 25,2 ± 4,3 Kg/m2. Median CCI was 4 [interquartile range (IQR) of 3]. Fifty-three patients (71,6%) were classified as robust (non-frail), 11 as vulnerable, and 10 as frail (8 mildly and 2 moderate). Patients were divided into two groups: A group included robust (non-frail) patients; B group included vulnerable and frail ones. Age, sex distribution, IMC, diabetes mellitus prevalence, variables related to PD (efficacy, vintage, modality and complications), and levels of hemoglobin, phosphorus, potassium and C-reactive protein were similar between the groups. Non frail patients presented significantly higher albumin levels and lower CCI (p-value < 0,05). A linear regression was performed to ascertain the effects of CCI and albumin: CCI was an independent predictor for frailty/vulnerability, accessed by EFS (for each point in CCI, there was an increase of 0,5 points in EFS). Albumin did not show a significant effect defining frailty in our sample. ROC curve showed a high accuracy for CCI to identify frail/ vulnerable patients (AUC 0,817). In our sample, CCI was an independent factor for frailty/vulnerability classified through EFS. In fact, it had a high accuracy to identify those patients, with a high sensibility. This means that CCI could be used as an acceptable screening test. However, the prevalence of frail/vulnerable patients was low in our sample. A larger one will allow to determine confirm if certain comorbidities, such as diabetes mellitus, or variables related to dialysis technique, are correlated with frailty. Furthermore, a larger sample would be essential to confirm whether albumin is, after all, a good predictor of frailty in the PD population, which was not confirmed in this work.
- 26 January 2023
- Published by S. Karger AG in Blood Purification
- Vol. 52 (4) , 366-372
Peritoneal Dialysis Exit-Site Care Protocols in Portugal and Its Association with Catheter-Related Infections
Introduction: Exit-site infection (ESi) prevention is a key factor in lowering the risk of peritonitis. This study aimed to evaluate the associations between exit-site (ES) care protocols and the annual incidence rates of ESi and peritonitis in Portugal. Methods: We performed a national survey using two questionnaires: one about the incidence of catheter-related infections and the other characterizing patients’ education and ES care protocols. Results: In 2017 and 2018, 14 Portuguese units followed 764 and 689 patients. ESi incidence rate was 0.41 episodes/year, and the peritonitis incidence rate was 0.37. All units monitor catheter-related infections on a yearly basis, use antibiotic prophylaxis at the time of catheter placement, and treat nasal carriage of S. aureus, although with different approaches. Screening for nasal carriage of S. aureus is performed by 12 units, and daily topical antibiotic cream is recommended by 6 out of 14 of the units. We did not find statistical differences in ESi/peritonitis, comparing these practices. The rate of ESis was lower with nonocclusive dressing immediately after catheter insertion, bathing without ES dressing, with the use of colostomy bags in beach baths and was higher with the use of bath sponge. The peritonitis rate was lower with bathing without ES dressing and if shaving of the external cuff was performed in the presence of chronic ESi. Conclusions: We found potential proceedings associated with ESi and peritonitis. A regular national audit of peritoneal dialysis units is an important tool for clarifying the best procedures for reduction of catheter-related infections.
- 26 January 2023
- Published by S. Karger AG in Blood Purification
- Vol. 52 (4) , 366-372
Peritoneal Dialysis Exit-Site Care Protocols in Portugal and Its Association with Catheter-Related Infections
Introduction: Exit-site infection (ESi) prevention is a key factor in lowering the risk of peritonitis. This study aimed to evaluate the associations between exit-site (ES) care protocols and the annual incidence rates of ESi and peritonitis in Portugal. Methods: We performed a national survey using two questionnaires: one about the incidence of catheter-related infections and the other characterizing patients’ education and ES care protocols. Results: In 2017 and 2018, 14 Portuguese units followed 764 and 689 patients. ESi incidence rate was 0.41 episodes/year, and the peritonitis incidence rate was 0.37. All units monitor catheter-related infections on a yearly basis, use antibiotic prophylaxis at the time of catheter placement, and treat nasal carriage of S. aureus, although with different approaches. Screening for nasal carriage of S. aureus is performed by 12 units, and daily topical antibiotic cream is recommended by 6 out of 14 of the units. We did not find statistical differences in ESi/peritonitis, comparing these practices. The rate of ESis was lower with nonocclusive dressing immediately after catheter insertion, bathing without ES dressing, with the use of colostomy bags in beach baths and was higher with the use of bath sponge. The peritonitis rate was lower with bathing without ES dressing and if shaving of the external cuff was performed in the presence of chronic ESi. Conclusions: We found potential proceedings associated with ESi and peritonitis. A regular national audit of peritoneal dialysis units is an important tool for clarifying the best procedures for reduction of catheter-related infections.
- 12 July 2021
- Published by Publicacoes Ciencia e Vida, Lda in Portuguese Journal of Nephrology & Hypertension
- Vol. 35 (2)
Peritoneal access – a pressing problem
In Portugal, as well as in Europe, peritoneal dialysis (PD) use remains low. Reorganization of PD units including a well -structured peritoneal access management protocol are fundamental to improve the take -up of this therapy. We analyzed the procedure and outcomes in a PD unit, addressing two key quality questions: at which level of estimated glomerular filtration rate (eGFR) were patients referred to peritoneal catheter placement and whether if it was timely placed. We retrospectively evaluated all patients submitted to catheter placement between 2017 and June 2020. We analyzed the patient journey from Kidney Replacement Therapies (KRT) Option Appointment, until PD start, as well as demographic and clinical variables, including eGFR at four time points (KRT Options Appointment, PD unit evaluation, catheter placement, and PD start). To explore the adequacy of catheter placement schedule, we compared the characteristics of the patients who started PD within 90 days of catheter placement (Early group), and of those who started after the first 90 days (Late group). We analyzed 48 patients in the Early and 27 in the Late group. The Early group presented a lower eGFR on KRT Options Appointment, with timely intervention: eGFR at catheter placement averaged 8.0 ± 2.1 mL/min/1,72m2. PD start occurred at 7.0 ± 1.9 and 8.0 ± 2.4 mL/min/1.72m2, in the Early and Late group, respectively. None of the patients suffered an urgent transition to HD by CVC. Four patients started PD less than 15 days after catheter placement, all of them without complications. PD patients’ admission involves specific tasks. Administrative tools or indicators to evaluate those processes are lacking. A peritoneal access clinic would allow the formalization of this circuit, allowing a quality and equitable approach to dialysis access. We suggest a structured pathway for peritoneal access management.
- 12 July 2021
- Published by Publicacoes Ciencia e Vida, Lda in Portuguese Journal of Nephrology & Hypertension
- Vol. 35 (2)
Peritoneal access – a pressing problem
In Portugal, as well as in Europe, peritoneal dialysis (PD) use remains low. Reorganization of PD units including a well -structured peritoneal access management protocol are fundamental to improve the take -up of this therapy. We analyzed the procedure and outcomes in a PD unit, addressing two key quality questions: at which level of estimated glomerular filtration rate (eGFR) were patients referred to peritoneal catheter placement and whether if it was timely placed. We retrospectively evaluated all patients submitted to catheter placement between 2017 and June 2020. We analyzed the patient journey from Kidney Replacement Therapies (KRT) Option Appointment, until PD start, as well as demographic and clinical variables, including eGFR at four time points (KRT Options Appointment, PD unit evaluation, catheter placement, and PD start). To explore the adequacy of catheter placement schedule, we compared the characteristics of the patients who started PD within 90 days of catheter placement (Early group), and of those who started after the first 90 days (Late group). We analyzed 48 patients in the Early and 27 in the Late group. The Early group presented a lower eGFR on KRT Options Appointment, with timely intervention: eGFR at catheter placement averaged 8.0 ± 2.1 mL/min/1,72m2. PD start occurred at 7.0 ± 1.9 and 8.0 ± 2.4 mL/min/1.72m2, in the Early and Late group, respectively. None of the patients suffered an urgent transition to HD by CVC. Four patients started PD less than 15 days after catheter placement, all of them without complications. PD patients’ admission involves specific tasks. Administrative tools or indicators to evaluate those processes are lacking. A peritoneal access clinic would allow the formalization of this circuit, allowing a quality and equitable approach to dialysis access. We suggest a structured pathway for peritoneal access management.
- Open Access
- 1 March 2020
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 42 (1) , 31-37
Does Cystatin C have a role as metabolic surrogate in peritoneal dialysis beyond its association with residual renal function?
Introduction: It has been suggested that cystatin C levels are modified by obesity and inflammation. Furthermore, cystatin C has been associated with cardiovascular events and mortality outcomes. Aim: To study the association of cystatin C with the metabolic profile and cardiovascular disease of peritoneal dialysis patients. Methods: Data collected included clinical, laboratorial, and multifrequency bioimpedance assessment of 52 stable peritoneal dialysis patients. Minimal residual renal function was defined as > 2mL/min/1.73m2. Results: Serum cystatin C was not significantly associated with peritoneal or urinary cystatin C excretion. Negative correlation of cystatin C with normalized protein catabolic rate (rho -0.33, p = 0.02) and a trend towards positive correlation with relative body fat (rho 0.27, p = 0.05) were not independent from residual renal function. Cystatin C was not significantly associated with cardiovascular disease (p = 0.28), nor with glycated hemoglobin (p = 0.19) or c-reactive protein (p = 0.56). In the multivariate model, both age and diabetes were the strongest predictors of cardiovascular disease (odds ratio 1.09, p = 0.029 and odds ratio 29.95, p = 0.016, respectively), while relative body fat was negatively associated with cardiovascular disease (p = 0.038); neither cystatin C (p = 0.096) nor minimal residual renal function (p = 0.756) reached a significant association with cardiovascular disease. Conclusions: In this group of peritoneal dialysis patients, cystatin C did not correlate with the metabolic or inflammatory status, nor cardiovascular disease, after adjustment for residual renal function.
- 1 March 2020
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 42 (1) , 31-37
Open AccessDoes Cystatin C have a role as metabolic surrogate in peritoneal dialysis beyond its association with residual renal function?
Introduction: It has been suggested that cystatin C levels are modified by obesity and inflammation. Furthermore, cystatin C has been associated with cardiovascular events and mortality outcomes. Aim: To study the association of cystatin C with the metabolic profile and cardiovascular disease of peritoneal dialysis patients. Methods: Data collected included clinical, laboratorial, and multifrequency bioimpedance assessment of 52 stable peritoneal dialysis patients. Minimal residual renal function was defined as > 2mL/min/1.73m2. Results: Serum cystatin C was not significantly associated with peritoneal or urinary cystatin C excretion. Negative correlation of cystatin C with normalized protein catabolic rate (rho -0.33, p = 0.02) and a trend towards positive correlation with relative body fat (rho 0.27, p = 0.05) were not independent from residual renal function. Cystatin C was not significantly associated with cardiovascular disease (p = 0.28), nor with glycated hemoglobin (p = 0.19) or c-reactive protein (p = 0.56). In the multivariate model, both age and diabetes were the strongest predictors of cardiovascular disease (odds ratio 1.09, p = 0.029 and odds ratio 29.95, p = 0.016, respectively), while relative body fat was negatively associated with cardiovascular disease (p = 0.038); neither cystatin C (p = 0.096) nor minimal residual renal function (p = 0.756) reached a significant association with cardiovascular disease. Conclusions: In this group of peritoneal dialysis patients, cystatin C did not correlate with the metabolic or inflammatory status, nor cardiovascular disease, after adjustment for residual renal function.
- Open Access
- 25 September 2018
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 23 (2) , 108-117
Diastolic Dysfunction, an Underestimated New Challenge in Dialysis
Heart failure (HF) is very common in the general population and specifically in CKD patients due to higher prevalence of traditional and CKD‐related risk factors. In particular, HF with preserved ejection fraction (HFpEF) can affect over 50% of dialysis patients. However, little is known about this entity in CKD. It has been inadequately recognized over time and few data exist regarding clinical profiles and outcomes in dialysis patients. The aim of this paper is to do a critical appraisal of the diagnosis, clinical impact, and management of HFpEF with a focus on new diagnostic criteria and its impact on dialysis.
- 25 September 2018
- Published by Wiley in Therapeutic Apheresis and Dialysis
- Vol. 23 (2) , 108-117
Open AccessDiastolic Dysfunction, an Underestimated New Challenge in Dialysis
Heart failure (HF) is very common in the general population and specifically in CKD patients due to higher prevalence of traditional and CKD‐related risk factors. In particular, HF with preserved ejection fraction (HFpEF) can affect over 50% of dialysis patients. However, little is known about this entity in CKD. It has been inadequately recognized over time and few data exist regarding clinical profiles and outcomes in dialysis patients. The aim of this paper is to do a critical appraisal of the diagnosis, clinical impact, and management of HFpEF with a focus on new diagnostic criteria and its impact on dialysis.